Showing posts with label Corporate Venture Capital. Show all posts
Showing posts with label Corporate Venture Capital. Show all posts
Thursday, April 24, 2014

Being a CVC - A perspective on Novartis Venture Fund's investment (& exit) strategy

›
If anything, the recent news of Novartis agreeing to sell its vaccine & veterinary businesses while simultaneously acquiring oncology...
1 comment:
Tuesday, January 21, 2014

Funds-on-Tap is passé & Drip-Funding is the new reality.

›
It’s probably been true for IT/ ITES ( particularly for e-commerce and social media & app-developers ) much longer, but for the drug...
Monday, July 22, 2013

The start-up investing winds, they are a-Changing OR are they?

›
In his latest, 'SuperLP' Chris Douvos  writes about the fears of an impending VC apocalypse....., okay to start with, in silicon va...
Monday, July 1, 2013

Cipla Ventures - What's the real story Gen-3?

›
Greed for quality & comprehension makes one less effective & less productive......... ........... Stash away those cudgels people,...
Wednesday, March 6, 2013

Will Mylan's acquisition of Agila benefit Accel Partners?

›
Okay, the story goes like this.... Way back in 2007, Accel partners committed to invest & invested over the next three years 1....
1 comment:
Tuesday, March 5, 2013

What could VCs learn from the recent pharma deals involving biotechs with very early-assets?

›
My response on the blog post " Preclinical Biotech Structured Deals: Reflections on 2013′s Solid Start"   by Bruce Booth - post...
Sunday, February 3, 2013

Pfizer Venture Investments (PVI) - a quick analysis of portfolio companies, categories

›
Trying to understand the driving factors behind the trends of life science investments in 2012, I was wondering if VC & CVCs behave dif...
1 comment:
Thursday, January 24, 2013

Is the LP bias against investment into life-sciences contra-logical?

›
17 January 2013 Early Stage Biotech Showing Positive Signs of Scaling Its Wall of Worry by Bruce Booth on Forbes http://www.fo...
1 comment: